Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.63 $3.11 Thursday, 9th May 2024 ABUS stock ended at $2.94. This is 3.52% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 5.36% from a day low at $2.80 to a day high of $2.95.
90 days $2.30 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Jun 23, 2020 $2.11 $2.20 $2.05 $2.05 1 159 054
Jun 22, 2020 $2.00 $2.10 $1.86 $2.04 1 249 881
Jun 19, 2020 $2.01 $2.07 $1.90 $1.91 2 367 920
Jun 18, 2020 $1.90 $2.08 $1.88 $1.96 670 931
Jun 17, 2020 $1.97 $2.08 $1.91 $1.91 661 444
Jun 16, 2020 $1.94 $2.00 $1.87 $1.98 792 501
Jun 15, 2020 $1.69 $1.95 $1.67 $1.84 990 965
Jun 12, 2020 $1.67 $1.76 $1.66 $1.73 570 577
Jun 11, 2020 $1.80 $1.80 $1.60 $1.64 1 282 256
Jun 10, 2020 $1.96 $1.97 $1.75 $1.85 1 209 590
Jun 09, 2020 $2.05 $2.10 $1.90 $1.91 1 320 795
Jun 08, 2020 $2.09 $2.09 $2.00 $2.05 1 188 116
Jun 05, 2020 $2.03 $2.15 $2.02 $2.05 1 224 096
Jun 04, 2020 $2.04 $2.18 $2.01 $2.04 2 098 887
Jun 03, 2020 $2.09 $2.19 $2.02 $2.06 1 308 771
Jun 02, 2020 $2.13 $2.25 $2.00 $2.09 1 049 055
Jun 01, 2020 $2.12 $2.23 $2.03 $2.16 685 763
May 29, 2020 $2.12 $2.21 $2.08 $2.17 450 563
May 28, 2020 $2.22 $2.25 $2.10 $2.16 464 727
May 27, 2020 $2.18 $2.29 $2.01 $2.22 1 202 840
May 26, 2020 $2.28 $2.29 $2.16 $2.21 824 133
May 22, 2020 $2.31 $2.36 $2.24 $2.29 810 003
May 21, 2020 $2.35 $2.42 $2.30 $2.34 725 134
May 20, 2020 $2.34 $2.36 $2.19 $2.36 2 760 373
May 19, 2020 $2.69 $2.69 $2.28 $2.31 12 105 355
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT